Moderna is moving at unprecedented speed to develop a vaccine to prevent infection from the novel coronavirus. But the biotech’s soaring stock price is moving faster, which raises an important question: Are investors taking on too much risk?
Since late February, Moderna shares have more than tripled in value — making it one of the top-performing biotech stocks this year. On Monday, shares hit an all-time high of $66.
About the Author Reprints
I used to subscribe to your service when you were at the street
Since then I have bee out of biotech
But I am considering getting back in
Before I subscribe I would be interested in your comments Radius Rdus . Prior to 17 I sold at 55 but now it’s in the low teens ????
Thank you
Keep up the good work!